Loading startup
Market data is refreshed once per day from public sources. Information may be incomplete or outdated — verify independently before making decisions. This is not investment advice.
Evidence-bound summary — expand sections for movement, risks, and signals.
Memo snapshot · May 20, 2026, 6:16 PM
What would change this read
DealFlow OS uses public web data and automated enrichment. Research may be incomplete, outdated, or incorrect. Verify important information before making investment or outreach decisions.
TL;DR
Seed (YC)HealthKey Clinical trial patient identification for sites.
Raised $500K across 1 funding round. Latest: $500K Pre-seed (Jan 2025). Investors: Y Combinator. (High).
Funding
Raised $500K across 1 funding round. Latest: $500K Pre-seed (Jan 2025). Investors: Y Combinator. (High).
Product / news
2 product/news‑styled row(s); headline risk without filings (High).
Verified facts
YC W25; AI prescreens EHR patients against clinical trial eligibility.
Weak funding evidence: mention does not include a parsed raise amount/round and may refer to non-funding context.
No open roles indexed yet.
The index price and activity score are algorithmic estimates based on observed public company-level signals. They may be incomplete, stale, or inaccurate and are not investment, legal, tax, or business advice.
Source types found
Strongest / recent news-style rows
Wed, May 20, 06:16 PM · confidence 88%high quality
Wed, May 20, 06:16 PM · confidence 85%medium quality
wikipedia · Mon, Jun 29, 06:18 AM · confidence 50%low quality
Newest first · 10 event(s)
Source: Blog
HealthKey uses AI to prescreen your entire EHR to surface patients who actually qualify for your clinical trials. Instead of CRCs spending hours manually scrubbing charts, we scan 80,000 patients and find the exact 42 who are eligible, ranked by how likely th…
Source: official_site
Helping find more patients for clinical trials 📑 Blog Home Product Contact Search Open main menu Blog Home Product Contact Helping find more patients for clinical trials 📑 HealthKey uses AI to prescreen your entire EHR to surface patients who actually quali…
Source: official_site
Notion JavaScript must be enabled in order to use Notion. Please enable JavaScript to continue.
Source: official_site
Boost Clinical Trial Enrollment - HealthKey How It Works Case Studies Pricing Schedule Demo Login Menu Menu AI-Powered Patient Identification for Clinical Trial Teams Integrate with your EHR and get emailed eligible patients for your clinical trials every day…
YC W25; AI prescreens EHR patients against clinical trial eligibility.
Source: Careers page
A collaborative AI workspace, built on your company context. Build and orchestrate agents right alongside your team's projects, meetings, and connected apps.
Doubles patient matches in half the time per launch.
Source: wikipedia
4 row(s)
The company's own site — the authoritative description of what they sell and to whom. Marketing-controlled, so treat claims as positioning rather than verified traction.
Helping find more patients for clinical trials 📑 Blog Home Product Contact Search Open main menu Blog Home Product Contact Helping find more patients for clinical trials 📑 HealthKey uses AI to prescreen your entire EHR to surface patients who actually quali…
Why it matters: Primary source — the company's own positioning; best read for what they sell and to whom, not for traction claims.
Open source ↗Notion JavaScript must be enabled in order to use Notion. Please enable JavaScript to continue.
Why it matters: Primary source — the company's own positioning; best read for what they sell and to whom, not for traction claims.
Open source ↗Boost Clinical Trial Enrollment - HealthKey How It Works Case Studies Pricing Schedule Demo Login Menu Menu AI-Powered Patient Identification for Clinical Trial Teams Integrate with your EHR and get emailed eligible patients for your clinical trials every day…
Why it matters: Primary source — the company's own positioning; best read for what they sell and to whom, not for traction claims.
Open source ↗Clinical trial patient identification for sites.
Why it matters: Primary source — the company's own positioning; best read for what they sell and to whom, not for traction claims.
Open source ↗3 row(s)
Third-party press coverage. Independent reporting corroborates company claims; repeated coverage across outlets is a momentum signal.
Doubles patient matches in half the time per launch.
Why it matters: Independent coverage — third-party corroboration of company claims; recurring coverage indicates rising visibility.
Open source ↗Why it matters: Independent coverage — third-party corroboration of company claims; recurring coverage indicates rising visibility.
Open source ↗Why it matters: Independent coverage — third-party corroboration of company claims; recurring coverage indicates rising visibility.
Open source ↗1 row(s)
Funding announcements and investor-database records. The strongest public signal of capitalization: round, amount, and syndicate quality when disclosed.
YC W25; AI prescreens EHR patients against clinical trial eligibility.
Why it matters: Funding signal — Pre-Seed per this source; verify against the linked original before relying on it.
Open source ↗1 row(s)
Open roles and careers pages. Active hiring implies runway to spend and shows where the company is investing (engineering vs GTM vs ops).
A collaborative AI workspace, built on your company context. Build and orchestrate agents right alongside your team's projects, meetings, and connected apps.
Why it matters: Hiring signal — open roles imply runway to spend and show where the company is investing.
Open source ↗1 row(s)
Company blog and newsletters. Shipping cadence and technical depth of posts hint at product velocity and team quality.
HealthKey uses AI to prescreen your entire EHR to surface patients who actually qualify for your clinical trials. Instead of CRCs spending hours manually scrubbing charts, we scan 80,000 patients and find the exact 42 who are eligible, ranked by how likely th…
Why it matters: Company publishing — post cadence and depth hint at product velocity.
Open source ↗Sign in as an active team member to view private notes, watchlist controls, transcript evidence, and interaction history.